AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

RecruitingOBSERVATIONAL
Enrollment

1,250

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
PROCEDURE

Standard of care liver biopsy

Patients undergoing a standard of care liver biopsy for any reason who are willing to participate will be consented for collecting additional biopsy tissue for research purposes. 1-2 additional biopsy tissue cores will be collected for research. Liver tissue will be biobanked for future use.

OTHER

Fibroscan

A FibroScan will be performed to evaluate longitudinal changes in liver fat and fibrosis.

OTHER

Biospecimen Collection

Blood and urine will be collected.

Trial Locations (1)

32804

RECRUITING

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
collaborator

BPGbio

INDUSTRY

lead

AdventHealth Translational Research Institute

OTHER